Loading clinical trials...
Loading clinical trials...
Mk0476 Phase II Dose Finding Study -Allergic Rhinitis-
Conditions
Interventions
MK0476, montelukast sodium / Duration of Treatment: 2 Weeks
Comparator: placebo / Duration of Treatment: 2 Weeks
Start Date
February 1, 2004
Primary Completion Date
March 1, 2004
Completion Date
March 1, 2004
Last Updated
August 15, 2024
Lead Sponsor
Organon and Co
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions